Exiqon 2013 Revenues Rise 5 Percent Despite a 16 Percent Drop in Q4 | GenomeWeb

NEW YORK (GenomeWeb News) – Exiqon today reported a 5 percent increase year over year in its revenues for 2013, while revenues in its fourth quarter shrank 16 percent.

The Danish firm said that total revenues in 2013 grew to DKK123.6 million ($22.6 million) from DKK117.4 million in 2012. Life Sciences revenues rose 6 percent to DKK118.4 million from DKK111.3 million, offsetting a 15 percent drop in Diagnostics revenues to DKK5.2 million from DKK6.1 million, Exiqon said in its annual report.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.